CN103494978B - 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 - Google Patents
使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 Download PDFInfo
- Publication number
- CN103494978B CN103494978B CN201310448919.2A CN201310448919A CN103494978B CN 103494978 B CN103494978 B CN 103494978B CN 201310448919 A CN201310448919 A CN 201310448919A CN 103494978 B CN103494978 B CN 103494978B
- Authority
- CN
- China
- Prior art keywords
- aloe
- powder
- ganoderma
- freeze
- dried powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 100
- 241001116389 Aloe Species 0.000 title claims abstract description 87
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 87
- 241000222336 Ganoderma Species 0.000 title claims abstract description 64
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 19
- 239000007924 injection Substances 0.000 title abstract description 24
- 238000002347 injection Methods 0.000 title abstract description 24
- 210000004185 liver Anatomy 0.000 title abstract 4
- 239000003814 drug Substances 0.000 claims abstract description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 239000000047 product Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 239000012153 distilled water Substances 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 6
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims abstract description 5
- 239000003708 ampul Substances 0.000 claims abstract description 4
- 238000005352 clarification Methods 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 206010003445 Ascites Diseases 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 17
- 230000002440 hepatic effect Effects 0.000 claims description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000009413 insulation Methods 0.000 claims description 6
- 230000002779 inactivation Effects 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 239000002826 coolant Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 229910052732 germanium Inorganic materials 0.000 claims description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical group [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 23
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960005277 gemcitabine Drugs 0.000 description 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000035777 life prolongation Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310448919.2A CN103494978B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 |
PCT/CN2013/001296 WO2015042756A1 (zh) | 2013-09-28 | 2013-10-28 | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 |
HK14103744.7A HK1190612A1 (zh) | 2013-09-28 | 2014-04-17 | 使用蘆薈、靈芝製備治療肝腹水瘤的凍乾粉針劑的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310448919.2A CN103494978B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103494978A CN103494978A (zh) | 2014-01-08 |
CN103494978B true CN103494978B (zh) | 2015-04-29 |
Family
ID=49860301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310448919.2A Expired - Fee Related CN103494978B (zh) | 2013-09-28 | 2013-09-28 | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN103494978B (zh) |
HK (1) | HK1190612A1 (zh) |
WO (1) | WO2015042756A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877437A (zh) * | 2014-02-25 | 2014-06-25 | 唐国荣 | 一种抗癌防癌的中药药物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108125A (zh) * | 1994-08-23 | 1995-09-13 | 中国中医研究院中药研究所 | 中国芦荟胶囊及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303711A (zh) * | 1999-12-02 | 2001-07-18 | 陈杏云 | 芦荟灵芝超细粉 |
CN1303099C (zh) * | 2004-06-28 | 2007-03-07 | 长春中医学院 | 松杉灵芝蛋白多糖混合物及其制备方法与应用 |
CN102512459A (zh) * | 2011-12-15 | 2012-06-27 | 浙江大学 | 一种无公害灵芝超微粉的制备方法及用途 |
-
2013
- 2013-09-28 CN CN201310448919.2A patent/CN103494978B/zh not_active Expired - Fee Related
- 2013-10-28 WO PCT/CN2013/001296 patent/WO2015042756A1/zh active Application Filing
-
2014
- 2014-04-17 HK HK14103744.7A patent/HK1190612A1/zh not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108125A (zh) * | 1994-08-23 | 1995-09-13 | 中国中医研究院中药研究所 | 中国芦荟胶囊及其制备方法 |
Non-Patent Citations (1)
Title |
---|
灵芝水煎剂对肝癌腹水瘤细胞系Hca-F25、CL-16A3的抗肿瘤作用的实验研究;张红等;《中药药理与临床》;19940531(第5期);第41页"3 讨论" * |
Also Published As
Publication number | Publication date |
---|---|
HK1190612A1 (zh) | 2014-07-11 |
WO2015042756A1 (zh) | 2015-04-02 |
CN103494978A (zh) | 2014-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102008528B (zh) | 复方海参制剂及其制备方法 | |
CN106729274A (zh) | 补肾壮阳保健养生组合物、其制备方法及用途 | |
CN102872206B (zh) | 一种提高免疫力、抗疲劳、改善性功能的中药复合物 | |
CN103103099B (zh) | 一种复方霍斛蓉芝保健酒及生产工艺 | |
CN105079046A (zh) | 一种全灵芝抗肿瘤软胶囊及其制备方法 | |
CN103405577B (zh) | 一种增强免疫力、缓解疲劳的药用组合物 | |
CN105434842A (zh) | 一种增强免疫力、改善睡眠的中药组合物及其制剂和制法 | |
CN103608025A (zh) | 用于预防或治疗神经退行性疾病的包含草药提取物的组合物 | |
WO2015190872A1 (ko) | 스피루리나 추출물을 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물 | |
CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
CN103494978B (zh) | 使用芦荟、灵芝制备治疗肝腹水瘤的冻干粉针剂的方法 | |
CN112370516A (zh) | 一种具有活性成分的破壁灵芝孢子粉制品及其制备方法 | |
CN104055935A (zh) | 一种协同提高免疫力的中药组合物 | |
CN102805836B (zh) | 一种治疗原发性肝癌的中药组合物及其制备方法 | |
KR101023487B1 (ko) | 오미자, 황금 및 해동피의 혼합 생약재 추출물을 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN108056461B (zh) | 一种黑木耳润肠功能咀嚼片及其制备方法 | |
CN106466280A (zh) | 一种远志宁心安神沐浴露及其制备方法 | |
CN101194714B (zh) | 儿童健脑营养液 | |
CN103238834A (zh) | 一种治疗皮肤瘙痒的组合物及其制备方法 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN101757039B (zh) | 一种守宫的仿生酶解产物及其用途 | |
CN103463377A (zh) | 使用芦荟粉制备芦荟注射液冻干粉针剂的方法 | |
CN103479845B (zh) | 使用芦荟、三七制备促进***分泌的冻干粉针剂的方法 | |
CN114588194A (zh) | 一种改善血稠及血管栓塞的生物成分组合 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1190612 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KAIFENG JIUFULAI BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HENAN JUFEEL SCIENCE + TECHNOLOGY GROUP CO., LTD. Effective date: 20150512 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 450000 ZHENGZHOU, HENAN PROVINCE TO: 475000 KAIFENG, HENAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150512 Address after: 475000 government office of Xinghua Road, Xinghua Road, Xinghua Town, Kaifeng City, Henan Province Patentee after: KAIFENG JUFEEL BIOLOGICAL TECHNOLOGY CO.,LTD. Address before: 450000, No. 21, building 2, No. 2106, East 16, agricultural road, Jinshui District, Henan, Zhengzhou Patentee before: Henan Jiufulai Technology Group Co.,Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1190612 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 |